These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24821477)

  • 1. Safety of sublingual immunotherapy in children.
    Frati F; Ridolo E; Fuiano N; Barberi S; Dell'Albani I; Landi M; Ricciardi L; Scala G; Incorvaia C
    Expert Opin Drug Saf; 2014 Jul; 13(7):947-53. PubMed ID: 24821477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen immunotherapy for respiratory allergy: to what extent can the risk of systemic reactions be reduced?
    Incorvaia C; Pucciarini F; Makri E; Gritti BL; Ridolo E
    Expert Opin Drug Saf; 2020 Jul; 19(7):843-848. PubMed ID: 32511028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of sublingual immunotherapy, can the rare systemic reactions be prevented?
    Cavaliere C; Incorvaia C; Begvarfaj E; Orlando MP; Turchetta R; Musacchio A; Ralli M; Ciofalo A; Greco A; de Vincentiis M; Masieri S
    Expert Opin Drug Saf; 2021 Mar; 20(3):259-264. PubMed ID: 33427529
    [No Abstract]   [Full Text] [Related]  

  • 4. Selection of patients for sublingual versus subcutaneous immunotherapy.
    Larenas Linnemann DE; Blaiss MS
    Immunotherapy; 2014; 6(7):871-84. PubMed ID: 25290418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy (SLIT)--indications, mechanism, and efficacy: Position paper prepared by the Section of Immunotherapy, Polish Society of Allergy.
    Jutel M; Bartkowiak-Emeryk M; Bręborowicz A; Cichocka-Jarosz E; Emeryk A; Gawlik R; Gonerko P; Rogala B; Nowak-Węgrzyn A; Samoliński B;
    Ann Agric Environ Med; 2016 Mar; 23(1):44-53. PubMed ID: 27012173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
    Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
    Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaphylaxis: still a ghost behind allergen immunotherapy.
    Makatsori M; Calderon MA
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):316-22. PubMed ID: 24873937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in all aspects.
    Hanci D; Şahin E; Muluk NB; Cingi C
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1347-55. PubMed ID: 25673026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of allergen immunotherapy in children.
    Schmidlin KA; Bernstein DI
    Curr Opin Allergy Clin Immunol; 2023 Dec; 23(6):514-519. PubMed ID: 37846900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Applications of Sublingual Immunotherapy.
    Edwards TS; Wise SK
    Otolaryngol Clin North Am; 2017 Dec; 50(6):1121-1134. PubMed ID: 29103453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of sublingual immunotherapy.
    Ciprandi G; Marseglia GL
    J Biol Regul Homeost Agents; 2011; 25(1):1-6. PubMed ID: 21382267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunotherapy for treating respiratory allergy: a review on its effectiveness and suitability.
    Incorvaia C; Fuiano N; Leo G
    Clin Ter; 2010; 161(6):543-7. PubMed ID: 21181085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local Side Effects of Sublingual and Oral Immunotherapy.
    Passalacqua G; Nowak-Węgrzyn A; Canonica GW
    J Allergy Clin Immunol Pract; 2017; 5(1):13-21. PubMed ID: 27527548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual immunotherapy: other indications.
    Passalacqua G; Compalati E; Canonica GW
    Immunol Allergy Clin North Am; 2011 May; 31(2):279-87, ix. PubMed ID: 21530820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual immunotherapy: what we can learn from the European experience.
    Linkov G; Toskala E
    Curr Opin Otolaryngol Head Neck Surg; 2014 Jun; 22(3):208-10. PubMed ID: 24801802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study.
    Bernardini R; Campodonico P; Burastero S; Azzari C; Novembre E; Pucci N; Massai C; De Martino M; Vierucci A
    Curr Med Res Opin; 2006 Aug; 22(8):1515-22. PubMed ID: 16870076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
    J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reaction to sublingual Parietaria vaccine following an ultra-rush induction.
    Scala G; Ciccarelli A; Calabrò C
    Eur Ann Allergy Clin Immunol; 2014 May; 46(3):116-8. PubMed ID: 24853571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.